Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Challenge Dose of Engerix-B in Previously Vaccinated Subjects
NCT00524576Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2007
- Primary completion
- May 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 2
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Nov 2007; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00524576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524576.